In This Post:
Presenters:
Elina Onitskansky
Founder & CEO
Chris Domian
Senior Manager, Benefits
As obesity rates continue to rise and GLP-1 medications reshape the healthcare landscape, employers are facing growing pressure to balance access, outcomes, and cost. During Shortlister’s latest Meet a Vendor webinar, attendees heard from Elina Onitskansky, Founder & CEO of Ilant Health, and Chris Domian, Senior Manager, Benefits at Amtrak, about how employers can take a more strategic approach to obesity and cardiometabolic care while delivering a better member experience.
The Growing Challenge of Obesity Care
One of the central themes of the discussion was the challenge many employers face as demand for GLP-1 medications continues to grow. For Amtrak, rapidly increasing pharmacy costs were a key driver in evaluating new solutions. GLP-1 spending had increased dramatically, creating pressure to find a more sustainable approach without limiting access to care.
However, cost was only one piece of the puzzle. Amtrak was also looking to improve clinical outcomes, gain greater visibility into member progress, and provide employees with a more personalized and supportive care experience. Traditional obesity management programs often focus primarily on medication access, leaving gaps in care, engagement, and long-term health outcomes.
Why Amtrak Chose a Different Approach
As Amtrak evaluated potential partners, the organization sought a solution that could address obesity as a complex, chronic condition rather than simply a pharmacy benefit challenge. The goal was to find a partner that could support employees throughout their entire health journey while helping the organization manage healthcare costs responsibly.
The webinar highlighted how obesity frequently coexists with other cardiometabolic conditions, making a comprehensive care strategy essential. Employers increasingly need solutions that deliver measurable outcomes while supporting diverse employee populations with varying health needs and treatment preferences.
Building an Ecosystem of Care
Rather than focusing solely on medication access, Ilant Health has built a comprehensive cardiometabolic care model designed to help right members receive the right treatment, with the right support. The program combines obesity medicine specialists, registered dietitians, mental health professionals, peer navigators, and digital health tools into a coordinated ecosystem of care.
Members receive individualized treatment recommendations that may include lifestyle modifications, anti-obesity medications, bariatric surgery, or a combination of approaches based on their unique needs. The model is designed to treat the whole person rather than focusing exclusively on weight loss.
Creating a Better Member Experience
A key differentiator discussed during the webinar was Ilant’s peer navigator model. Members receive personalized guidance and support throughout their care journey, helping them stay engaged and overcome barriers to treatment.
Combined with a dedicated clinical team and digital tools, this high-touch approach creates a more personalized and supportive experience while helping members achieve long-term success.
Delivering Measurable Value
Another area that resonated with attendees was the program’s transparent pricing structure. Employers are increasingly seeking solutions that demonstrate measurable value, particularly as obesity-related healthcare costs continue to rise.
Ilant’s pricing model is tied to active member engagement and includes clinical care, technology, implementation support, and ongoing management within a single fee structure. The program also incorporates performance guarantees tied to member experience, clinical outcomes, and financial results, helping employers better align investment with value delivered.
This transparent, all-inclusive approach was highlighted as an important differentiator because it provides greater clarity into costs while reinforcing accountability for outcomes.
Early Insights and What's Next
The webinar also provided insight into Amtrak’s implementation experience. Both organizations emphasized the importance of proactive communication and education when introducing a new healthcare benefit.
Early observations have been encouraging, with strong member engagement, frequent clinical interactions, and opportunities to better align treatment plans with individual needs. Looking ahead, employers will need solutions that can adapt to the evolving GLP-1 landscape while maintaining a focus on outcomes, member experience, and affordability.
Connect with Ilant Health!
As employers continue to navigate rising obesity rates and growing demand for GLP-1 medications, innovative care models are becoming increasingly important. The webinar reinforced an important takeaway: addressing obesity and cardiometabolic health requires more than a prescription. Sustainable results come from combining clinical expertise, personalized support, ongoing engagement, and a care model designed around the individual.
To learn more about Ilant Health’s approach to obesity and cardiometabolic care, or to discuss how their model can help your organization improve outcomes while managing costs, connect with the Ilant Health team. Their experts can provide additional insights into implementation strategies, clinical outcomes, and how employers can build a more effective and sustainable obesity care benefit for their populations.
For more information, contact:
In case you missed it: Log in to access the full Meet A Vendor Presentation!
Not a subscriber? Request access.
Did you find this article interesting?
Don’t keep this knowledge to yourself – share it on your social media channels and spark engaging conversations!